Oral self-administration of pregabalin in a mouse model and the resulting drug addiction features.

Publication Year: 2023

DOI:
10.1016/j.jsps.2023.101935

PMCID:
PMC10825552

PMID:
38292403

Journal Information

Full Title: Saudi Pharm J

Abbreviation: Saudi Pharm J

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Pharmacology & Pharmacy

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper."

Evidence found in paper:

"The author expresses gratitude to Mashhour Alsufyani, Fahad Almutairi, Abdulbari Althobaiti, and Mohammed Alhazmi for their valuable assistance with the FST and TST. The author extends sincere appreciation to Jamjoom Pharmaceuticals for their generous supply of pregabalin. The author extends appreciation to the Deanship of Graduate Studies and Scientific Research at Taif University for funding this study. Role of the Funding Source The author thanks the Deanship of Graduate Studies and Scientific Research at Taif University for funding this work."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025